Miragen Therapeutics, Inc. (MGEN): Price and Financial Metrics
MGEN Price/Volume Stats
| Current price | $23.01 | 52-week high | $34.05 |
| Prev. close | $23.03 | 52-week low | $4.66 |
| Day low | $22.97 | Volume | 44,300 |
| Day high | $23.90 | Avg. volume | 134,027 |
| 50-day MA | $18.20 | Dividend yield | N/A |
| 200-day MA | $14.23 | Market Cap | 89.92M |
MGEN Stock Price Chart Interactive Chart >
Miragen Therapeutics, Inc. (MGEN) Company Bio
Miragen Therapeutics, Inc., a clinical stage biopharmaceutical company, develops microRNA-targeted therapies for various unmet medical needs. It focuses on various therapeutic areas, such as cancer, pathologic fibrosis, neuro-inflammatory, and cardiovascular diseases. The company was founded in 2006 and is based in Boulder, Colorado.
MGEN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 151.48% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 128.52% |
| 2019 | -84.16% |
Continue Researching MGEN
Want to see what other sources are saying about Miragen Therapeutics Inc's financials and stock price? Try the links below:Miragen Therapeutics Inc (MGEN) Stock Price | Nasdaq
Miragen Therapeutics Inc (MGEN) Stock Quote, History and News - Yahoo Finance
Miragen Therapeutics Inc (MGEN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...